News ZhuZhou QianJin Pharmaceutical Co.,Ltd

Equities

600479

CNE000001GX3

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
11.34 ^CNY	-1.05%		-1.22%	+5.29%

Jan. 24	Qianjin Pharma Unit Gets Nod for Supplemental New Drug Application for Teralithe Biosimilar	MT
Jan. 18	ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qianjin Pharma Unit Gets Nod for Supplemental New Drug Application for Teralithe Biosimilar	Jan. 24	MT
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Jan. 18	CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it has received CNY 50 million in funding from a group of investors	Dec. 20	CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announces tranche update	Dec. 16	CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it expects to receive CNY 310 million in funding from ZhuZhou QianJin Pharmaceutical Co.,Ltd, Capstone Strategic, Inc.	Dec. 05	CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 million in funding from ZhuZhou QianJin Pharmaceutical Co.,Ltd	23-10-17	CI
ZhuZhou QianJin Pharma Gets Nod to Register Blood Circulation Drug in Canada	23-10-10	MT
QianJin Pharma’s Product Selected Among Top 100 Evidenced-Based Traditional Chinese Medicines	23-09-08	MT
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-12	CI
Zhuzhou Qianjin Pharma's Unit Gets Nod for Chronic Hepatitis B Drug	23-04-10	MT
ZhuZhou QianJin Pharma Promotes Vice Chairman to Chairman	23-03-17	MT
Zhuzhou QianJin Pharmaceutical's Chairman Resigns; Shares Rose 5%	23-03-15	MT
ZhuZhou QianJin Pharma Appoints Vice Chairman	22-12-20	MT
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-27	CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
ZhuZhou QianJin Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2021	22-01-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ZhuZhou QianJin Pharmaceutical Co.,Ltd

Equities

600479

CNE000001GX3

Summary

Filters